Results from a phase III randomized, placebo-controlled clinical trial evaluating adjuvant endocrine therapy +/-1 year of everolimus in patients with high-risk hormone receptor-positive, HER2-negative breast cancer: SWOG S1207 Marianna Chavez,Jieling Miao,Lajos Pusztai,Matthew P. Goetz,Priya Rastogi,Patricia A. Ganz,Eleftherios (Terry) Mamounas,Soonmyung Paik,Hanna Bandos, Wajeeha Razaq,Anne O'Dea,Virginia Kaklamani,Andrea L. M. Silber,Lisa E. Flaum, Eleni Andreopolu, Joseph Baar, Albert G. Wendt, Jennifer F. Carney,Priyanka Sharma,Julie R. Gralow,Danika L. Lew,William E. Barlow,Gabriel N. HortobagyiCANCER RESEARCH（2023）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
